• Live Feeds
    • Press Releases
    • Insider Trading
    • FDA Approvals
    • Analyst Ratings
    • Insider Trading
    • SEC filings
    • Market insights
  • Analyst Ratings
  • Alerts
  • Subscriptions
  • Settings
  • RSS Feeds
Quantisnow Logo
  • Live Feeds
    • Press Releases
    • Insider Trading
    • FDA Approvals
    • Analyst Ratings
    • Insider Trading
    • SEC filings
    • Market insights
  • Analyst Ratings
  • Alerts
  • Subscriptions
  • Settings
  • RSS Feeds
PublishGo to App
    Quantisnow Logo

    © 2026 quantisnow.com
    Democratizing insights since 2022

    Services
    Live news feedsRSS FeedsAlertsPublish with Us
    Company
    AboutQuantisnow PlusContactJobsAI superconnector for talent & startupsNEWLLM Arena
    Legal
    Terms of usePrivacy policyCookie policy

    Dow Falls Over 1%; US Inflation Rate Accelerates In March

    4/10/24 10:20:54 AM ET
    $ADIL
    $ASTI
    $MRIN
    $VIAO
    Biotechnology: Pharmaceutical Preparations
    Health Care
    Semiconductors
    Technology
    Get the next $ADIL alert in real time by email

    U.S. stocks traded lower this morning, with the Dow Jones index falling more than 1% on Wednesday.

    Following the market opening Wednesday, the Dow traded down 1.21% to 38,414.32 while the NASDAQ fell 0.98% to 16,147.16. The S&P 500 also fell, dropping, 0.99% to 5,158.18.

    Check This Out: How To Earn $500 A Month From Citigroup Stock Ahead Of Q1 Earnings Report

     

    Leading and Lagging Sectors

     

    Energy shares rose by 0.1% on Wednesday.

    In trading on Wednesday, real estate shares fell by 3.4%.

     

    Top Headline

     

    U.S. annual inflation rate rose for a second consecutive month to 3.5% in March from 3.2% in February.

     

    Equities Trading UP

     

    Marin Software Incorporated (NASDAQ:MRIN) shares shot up 132% to $0.6669 after the company announced upgrades to its integration with Microsoft Advertising.

    Shares of Adial Pharmaceuticals, Inc. (NASDAQ:ADIL) got a boost, surging 84% to $2.0840 after the company announced the publication of a peer-reviewed article highlighting the clinical results, strong safety profile, and high compliance among patients administered AD04.

    Meiwu Technology Company Limited (NASDAQ:WNW) shares were also up, gaining 43% to $1.44.

     

    Equities Trading DOWN

     

    VIA optronics AG (NYSE:VIAO) shares dropped 59% to $0.3661. VIA optronics and Antolin unveiled Sunrise, a new horizon of integration in vehicle cockpits.

    Shares of Ascent Solar Technologies, Inc. (NASDAQ:ASTI) were down 50% to $0.1374 after the company announced pricing of a $6 million public offering of shares at $0.14 per share.

    Velo3D, Inc. (NYSE:VLD) was down, falling 41% to $0.2750 after the company announced pricing of a $12 million public offering.

    Also Check This Out: Around $1M Bet On This Healthcare Stock? Check Out These 3 Penny Stocks Insiders Are Buying

     

    Commodities

     

    In commodity news, oil traded up 0.1% to $85.27 while gold traded down 0.4% at $2,353.50.

    Silver traded up 0.3% to $28.065 on Wednesday, while copper fell 0.4% to $4.2680.

     

    Euro zone

     

    European shares were lower today. The eurozone’s STOXX 600 fell 0.2%, London’s FTSE 100 fell 0.1% while Spain’s IBEX 35 Index fell 0.8% The German DAX fell 0.1% French CAC 40 fell 0.5% while Italy’s FTSE MIB Index fell 0.1%.

    The value of retail sales in Italy rose by 0.1% from the prior month in February.

     

    Asia Pacific Markets

     

    Asian markets closed mixed on Wednesday, with Japan’s Nikkei 225 falling 0.48%, Hong Kong’s Hang Seng Index gaining 1.85%, China’s Shanghai Composite falling 0.70% and India’s S&P BSE Sensex gaining 0.47%.

    Producer prices in Japan rose by 0.8% year-over-year in March, while value of loans rose 3.2% year-over-year in March. Chinese vehicle sales climbed by 9.9% year-over-year to 2.69 million units in March compared to a 19.9% decline in the previous month.

     

    Economics

     

    U.S. mortgage applications rose 0.1% on the week ending April 5, 2024.

    U.S. annual inflation rate rose for a second consecutive month to 3.5% in March from 3.2% in February.

    Now Read This: Tesla To $205? Here Are 10 Top Analyst Forecasts For Wednesday

    Get the next $ADIL alert in real time by email

    Crush Q1 2026 with the Best AI Superconnector

    Stay ahead of the competition with Standout.work - your AI-powered talent-to-startup matching platform.

    AI-Powered Inbox
    Context-aware email replies
    Strategic Decision Support
    Get Started with Standout.work

    Recent Analyst Ratings for
    $ADIL
    $ASTI
    $MRIN
    $VIAO

    CompanyDatePrice TargetRatingAnalyst
    Adial Pharmaceuticals Inc
    $ADIL
    11/14/2024$8.00Buy
    Rodman & Renshaw
    Velo3D Inc.
    $VLD
    8/17/2022$5.40Neutral
    Credit Suisse
    Velo3D Inc.
    $VLD
    3/4/2022$7.00Neutral → Underperform
    B of A Securities
    Velo3D Inc.
    $VLD
    10/26/2021$15.00Buy
    Needham
    Velo3D Inc.
    $VLD
    10/25/2021Outperform
    William Blair
    Adial Pharmaceuticals Inc
    $ADIL
    10/13/2021$12.00Buy
    Brookline Capital
    Adial Pharmaceuticals Inc
    $ADIL
    6/29/2021$5.00Buy
    Litchfield Hills
    More analyst ratings

    $ADIL
    $ASTI
    $MRIN
    $VIAO
    SEC Filings

    View All

    Amendment: SEC Form S-3/A filed by Ascent Solar Technologies Inc.

    S-3/A - Ascent Solar Technologies, Inc. (0001350102) (Filer)

    2/9/26 4:10:29 PM ET
    $ASTI
    Semiconductors
    Technology

    Adial Pharmaceuticals Inc filed SEC Form 8-K: Material Modification to Rights of Security Holders, Amendments to Articles of Incorporation or Bylaws; Change in Fiscal Year, Other Events, Financial Statements and Exhibits

    8-K - ADIAL PHARMACEUTICALS, INC. (0001513525) (Filer)

    2/4/26 4:30:34 PM ET
    $ADIL
    Biotechnology: Pharmaceutical Preparations
    Health Care

    Amendment: SEC Form 6-K/A filed by Meiwu Technology Company Limited

    6-K/A - Meiwu Technology Co Ltd (0001787803) (Filer)

    2/3/26 4:15:15 PM ET
    $WNW
    Catalog/Specialty Distribution
    Consumer Discretionary

    $ADIL
    $ASTI
    $MRIN
    $VIAO
    Analyst Ratings

    Analyst ratings in real time. Analyst ratings have a very high impact on the underlying stock. See them live in this feed.

    View All

    Rodman & Renshaw initiated coverage on Adial Pharmaceuticals with a new price target

    Rodman & Renshaw initiated coverage of Adial Pharmaceuticals with a rating of Buy and set a new price target of $8.00

    11/14/24 7:21:37 AM ET
    $ADIL
    Biotechnology: Pharmaceutical Preparations
    Health Care

    Credit Suisse initiated coverage on Velo3D with a new price target

    Credit Suisse initiated coverage of Velo3D with a rating of Neutral and set a new price target of $5.40

    8/17/22 8:26:27 AM ET
    $VLD
    Industrial Machinery/Components
    Technology

    Velo3D downgraded by B of A Securities with a new price target

    B of A Securities downgraded Velo3D from Neutral to Underperform and set a new price target of $7.00

    3/4/22 7:05:35 AM ET
    $VLD
    Industrial Machinery/Components
    Technology

    $ADIL
    $ASTI
    $MRIN
    $VIAO
    Press Releases

    Fastest customizable press release news feed in the world

    View All

    Ascent Solar Technologies Spurs Development of CIGS PV Modules Capable of Generating Multiple Times More Power for Space Beaming

    THORNTON, Colo., Feb. 05, 2026 (GLOBE NEWSWIRE) -- Ascent Solar Technologies ("Ascent" or the "Company") (NASDAQ:ASTI), today announced its plans to continue development of distributed power receiving products in 2026 to account for growing demand for space-based energy beaming technologies. These development efforts include both internally funded research and development as well as continued Collaborative Agreement Notice program work with the NASA Marshall Spaceflight Center and Glenn Research Center, which is on schedule to successfully conclude this spring. The Company plans to present the results of these development programs at select space industry conferences to be announced later

    2/5/26 8:00:00 AM ET
    $ASTI
    Semiconductors
    Technology

    Adial Applauds Congressional Directive Advancing Alternative Clinical Trial Endpoints for Substance Use Disorders, Strengthening Regulatory Path for AD04

    GLEN ALLEN, Va., Feb. 04, 2026 (GLOBE NEWSWIRE) -- Adial Pharmaceuticals, Inc. (NASDAQ:ADIL) ("Adial" or the "Company"), a clinical-stage biopharmaceutical company focused on developing therapies for the treatment and prevention of addiction and related disorders, today applauded the passage by Congress and signing into law by President Donald J. Trump of the Departments of Labor, Health and Human Services, and Education, and Related Agencies Appropriations Bill, 2026. The final legislation incorporates Senate Report 119-55, which includes a significant Congressional directive to the U.S. Food and Drug Administration (FDA) and the National Institute on Drug Abuse (NIDA) to collaborate on

    2/4/26 9:35:00 AM ET
    $ADIL
    Biotechnology: Pharmaceutical Preparations
    Health Care

    Adial Pharmaceuticals Announces Reverse Stock Split to Regain Compliance with Nasdaq's Minimum Bid Price Requirement

    GLEN ALLEN, Va., Feb. 03, 2026 (GLOBE NEWSWIRE) -- Adial Pharmaceuticals, Inc. (NASDAQ:ADIL) ("Adial" or the "Company"), a clinical-stage biopharmaceutical company focused on developing therapies for the treatment and prevention of addiction and related disorders, today announced that it will effect a 1-for-25 reverse stock split (the "Reverse Split") of its common stock, par value $0.001 per share ("Common Stock"), that will become effective on February 5, 2026 at 11:59 p.m. Eastern Time (the "Effective Time"). Adial's Common Stock will continue to trade on the Nasdaq Capital Market ("Nasdaq") under the symbol "ADIL" and will begin trading on a split-adjusted basis when the Nasdaq opens o

    2/3/26 4:05:00 PM ET
    $ADIL
    Biotechnology: Pharmaceutical Preparations
    Health Care

    $ADIL
    $ASTI
    $MRIN
    $VIAO
    Insider Trading

    Insider transactions reveal critical sentiment about the company from key stakeholders. See them live in this feed.

    View All

    Director Forrest Reynolds T. sold $2,407 worth of shares (521 units at $4.62), decreasing direct ownership by 63% to 312 units (SEC Form 4)

    4 - Ascent Solar Technologies, Inc. (0001350102) (Issuer)

    1/7/26 5:26:25 PM ET
    $ASTI
    Semiconductors
    Technology

    Director Forrest Reynolds T. sold $197,241 worth of shares (38,827 units at $5.08), decreasing direct ownership by 98% to 833 units (SEC Form 4)

    4 - Ascent Solar Technologies, Inc. (0001350102) (Issuer)

    12/29/25 1:30:22 PM ET
    $ASTI
    Semiconductors
    Technology

    Director Forrest Reynolds T. converted options into 38,827 shares, increasing direct ownership by 4,661% to 39,660 units (SEC Form 4)

    4 - Ascent Solar Technologies, Inc. (0001350102) (Issuer)

    12/19/25 8:45:01 PM ET
    $ASTI
    Semiconductors
    Technology

    $ADIL
    $ASTI
    $MRIN
    $VIAO
    Insider Purchases

    Insider purchases reveal critical bullish sentiment about the company from key stakeholders. See them live in this feed.

    View All

    Director Peterson David Theodore Jr bought $6,178 worth of shares (66,000 units at $0.09), increasing direct ownership by 157% to 108,152 units (SEC Form 4)

    4 - Ascent Solar Technologies, Inc. (0001350102) (Issuer)

    7/2/24 6:30:04 PM ET
    $ASTI
    Semiconductors
    Technology

    Chief Executive Officer Warley Paul P. bought $1,862 worth of shares (15,000 units at $0.12), increasing direct ownership by 6% to 246,538 units (SEC Form 4)

    4 - Ascent Solar Technologies, Inc. (0001350102) (Issuer)

    6/12/24 5:53:56 PM ET
    $ASTI
    Semiconductors
    Technology

    Forrest Reynolds T. bought $5,999 worth of shares (6,160 units at $0.97), increasing direct ownership by 12% to 58,243 units (SEC Form 4)

    4 - Ascent Solar Technologies, Inc. (0001350102) (Issuer)

    11/20/23 7:34:39 PM ET
    $ASTI
    Semiconductors
    Technology

    $ADIL
    $ASTI
    $MRIN
    $VIAO
    Large Ownership Changes

    This live feed shows all institutional transactions in real time.

    View All

    Amendment: SEC Form SC 13G/A filed by Adial Pharmaceuticals Inc

    SC 13G/A - ADIAL PHARMACEUTICALS, INC. (0001513525) (Subject)

    11/14/24 3:44:01 PM ET
    $ADIL
    Biotechnology: Pharmaceutical Preparations
    Health Care

    SEC Form SC 13D/A filed by Velo3D Inc. (Amendment)

    SC 13D/A - Velo3D, Inc. (0001825079) (Subject)

    5/3/24 6:15:31 PM ET
    $VLD
    Industrial Machinery/Components
    Technology

    SEC Form SC 13G filed by Adial Pharmaceuticals Inc

    SC 13G - ADIAL PHARMACEUTICALS, INC. (0001513525) (Subject)

    2/14/24 3:22:13 PM ET
    $ADIL
    Biotechnology: Pharmaceutical Preparations
    Health Care

    $ADIL
    $ASTI
    $MRIN
    $VIAO
    Leadership Updates

    Live Leadership Updates

    View All

    Adial Pharmaceuticals Reports 2024 Fiscal Year Financial Results and Provides Business Update

    GLEN ALLEN, Va., March 04, 2025 (GLOBE NEWSWIRE) -- Adial Pharmaceuticals, Inc. (NASDAQ:ADIL) ("Adial" or the "Company"), a clinical-stage biopharmaceutical company focused on developing therapies for the treatment and prevention of addiction and related disorders, today provided a business update and reported its financial results for the 2024 fiscal year ended December 31, 2024. Key Highlights Successful completion of AD04-103 pharmacokinetics (PK) study of AD04, corroborating bioavailability, dose proportionality, no food effect, and safety profile consistent with the use of Ondansetron. Advancement towards pivotal Phase 3 trial design supportive of ongoing partnership

    3/4/25 8:30:00 AM ET
    $ADIL
    Biotechnology: Pharmaceutical Preparations
    Health Care

    Adial Pharmaceuticals Reports Third Quarter 2024 Financial Results and Provides Business Update

    GLEN ALLEN, Va., Nov. 13, 2024 (GLOBE NEWSWIRE) -- Adial Pharmaceuticals, Inc. (NASDAQ:ADIL) ("Adial" or the "Company"), a clinical-stage biopharmaceutical company focused on developing therapies for the treatment and prevention of addiction and related disorders, today provided a business update and reported its financial results for the third quarter of 2024. Cary Claiborne, President and Chief Executive Officer of Adial, stated, "We reached an important milestone this quarter with the successful database lock of the pharmacokinetics study for AD04, our lead investigational, genetically targeted therapeutic for the treatment of Alcohol Use Disorder (AUD). The pharmacokinetics study is e

    11/13/24 8:30:00 AM ET
    $ADIL
    Biotechnology: Pharmaceutical Preparations
    Health Care

    Adial Pharmaceuticals Appoints Vinay Shah as Chief Financial Officer

    GLEN ALLEN, Va., Nov. 05, 2024 (GLOBE NEWSWIRE) -- Adial Pharmaceuticals, Inc. (NASDAQ:ADIL) ("Adial" or the "Company"), a clinical-stage biopharmaceutical company focused on developing therapies for the treatment and prevention of addiction and related disorders, today announced the appointment of Vinay Shah as the Company's Chief Financial Officer, effective November 16, 2024. Vinay Shah is an accomplished Chief Financial Officer with over 25 years of experience in the pharmaceutical, biopharmaceutical, and healthcare sectors, specializing in financial strategy, investor relations, and operational efficiency. Most recently, Mr. Shah served as the CFO at Virpax Pharmaceuticals, Inc. (N

    11/5/24 8:30:00 AM ET
    $ADIL
    $VRPX
    Biotechnology: Pharmaceutical Preparations
    Health Care

    $ADIL
    $ASTI
    $MRIN
    $VIAO
    Financials

    Live finance-specific insights

    View All

    Marin Software Announces Third Quarter 2024 Financial Results

    Marin Software Incorporated (NASDAQ:MRIN) ("Marin", "Marin Software" or the "Company"), a leading provider of digital marketing software for performance-driven advertisers and agencies, today announced financial results for the third quarter ended September 30, 2024. "Marin is excited to deliver the next generation of AI-powered performance marketing tools with our latest enhancement, Advisor," said Chris Lien, Marin Software's CEO. "With this OpenAI-powered virtual teammate, Marin users can interact with the platform in an entirely new way – unlocking the collective knowledge of digital marketing thought leaders and putting their best practices to work with a simple prompt. This is anothe

    10/31/24 4:14:00 PM ET
    $MRIN
    EDP Services
    Technology

    Marin Software Announces Date of Third Quarter 2024 Financial Results Conference Call

    Marin Software Incorporated (NASDAQ:MRIN), a leading provider of digital marketing software for performance-driven advertisers and agencies, today announced it will report financial results for the quarter ended September 30, 2024, after market close on Thursday, October 31, 2024. The company also announced it will hold a conference call on the same day at 2:00 PM Pacific Time (5:00 PM Eastern Time) to discuss its quarterly financial results. This conference call may include forward-looking statements. The conference call can be accessed by dialing (877) 704-4453 from the United States or +1 (201) 389-0920 internationally with conference ID 13742154, and a live webcast of the conference ca

    10/16/24 4:30:00 PM ET
    $MRIN
    EDP Services
    Technology

    Meiwu Technology Company Limited Received Nasdaq Notification Letter Regarding Bid Price Deficiency

    Shenzhen, China, Sept. 11, 2024 (GLOBE NEWSWIRE) -- Meiwu Technology Company Limited ("WNW" or the "Company"), (NASDAQ:WNW) announced today that on September 10, 2024, the Company received a notification letter from the Nasdaq Listing Qualifications Staff of The NASDAQ Stock Market LLC ("Nasdaq") notifying the Company that the minimum bid price per share for its ordinary shares has been below $1.00 for a period of 30 consecutive business days and the Company therefore no longer meets the minimum bid price requirements set forth in Nasdaq Listing Rule 5550(a)(2). The notification received has no immediate effect on the listing of the Company's ordinary shares on Nasdaq. Under the Nasdaq Li

    9/11/24 4:15:00 PM ET
    $WNW
    Catalog/Specialty Distribution
    Consumer Discretionary